EXOSOME-TARGETING BISPECIFIC ANTIBODIES
The inventions described herein are directed to bispecific antibodies that are capable of selectively targeting exosomes by specifically binding a first exosome-associated protein and Programmed Death Ligand-1 ("PD-L1") as a second exosome-associated protein. These bispecific antibodies ca...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!